Emory to conduct H1N1 vaccine trial in asthma sufferers
The Atlanta Journal-Constitution
Emory University will participate in a clinical trial to study what dose of the 2009 H1N1 vaccine is needed to build up an effective immunity in people with asthma, particularly those with severe cases of the respiratory disease.
The study is co-sponsored by the National Institute of Allergy and Infectious Diseases and the National Heart, Lung and Blood Institute, both are part of the National Institutes of Health.
People with underlying conditions, such as asthma, are at greater risk of developing complications from the disease. The trials will be conducted at Emory and six other sites that participate in the NHLBI's Severe Asthma Research Program. At Emory, the program is through the Emory-Children's Center, which is jointly run by Emory and Children's Healthcare of Atlanta.
About 350 people with mild, moderate and severe asthma will be enrolled in the overall study. At Emory, no volunteers are needed. The participants will be selected from people already involved in the exisiting asthma research program.
More on ajc.com
Related Topics
Inside AJC.COM
My Style
Kristi York Wooten biggest fashion weakness? 'Coleccion Luna handbags' designed by a friend.
Best soup in Atlanta
When the weather turns chilly, our thoughts turn to steaming bowls of soup. Who has the best?
Black Friday sales leaked
Target rolls out price matching for the first time, and Walmart looks to discount electronics.
Can you see the change?
What's altered in the two photos? See how you score when you play the Find 5 challenge!
Is Sheree a goner?
Rodney Ho reports on a source that says she has been booted off 'Real Housewives of Atlanta'.
Private Quarters Splurge
This six-bedroom, 6.5 bath home occupies 10,600 square feet for these Georgia Tech fans.
.JPG)
Services »
